Search for clinically relevant imaging biomarkers in a multicenter study of anal squamous cell carcinoma patients using Deep Learning and Radiomics

Anal carcinoma constitutes a rare disease. Radiochemotherapy constitutes the current standard of care, but achieves only limited healing rates. So far, no clinical, molecular, or pathological parameter has been identified to adjust the given therapy to individual patients. The proposed project aims to analyze the potential of quantitative analysis of medical imaging data (“radiomics”) and artificial intelligence techniques for improved prediction of patients’ survival. The resulting image-based prediction models may be used for improved patient risk assessment in the future.

Optimised bisacylphosphane oxides and tailored photonic crystal fibers for gentle photolatent cancer therapy

Cancer is a leading cause of death worldwide. Despite progress in therapy, new approaches to cure cancer are urgently needed. Such an approach is the topic of this project: It investigates small molecules that are completely non-toxic for cells. However, if they are activated by light, they fragment into smaller parts, which are very toxic, killing cells quickly. For activation, special light guides are needed, which precisely deliver the light to the desired spot – here, the cancer cells. Such lights are developed in this project, too.

Gesund essen – trotz Corona!

Wie haben sich die Ess-, Trink- und Bewegungsgewohnheiten von Kindern seit Beginn der Corona-Pandemie verändert? Diesem Thema haben sich Experten des Else Kröner Fresenius Zentrums für Ernährungsmedizin (EKFZ) an der Technischen Universität München (TUM) gewidmet. Rund die Hälfte der zehn- bis 14-jährigen Kinder bewegen sich der Studie zufolge weniger. Vor allem die älteren Kinder essen seit dem Lockdown auch mehr Süßes und Salziges. Die Studie markiert den Startpunkt für den neuen Themenschwerpunkt „Ernährung im Kindesalter“ am EKFZ.

Deciphering the role of an E3 ubiquitin ligase HectD3 in cardiac pathophysiology

Heart failure is the leading cause of mortality and hospitalizations worldwide and the numbers are ever increasing. Cardiac hypertrophy and chronic inflammation are two of the major molecular causes of a failing heart. Thus, either or both of these molecular mechanisms can potentially be therapeutically targeted. Based on our in vitro and preliminary in vivo studies, in this project, we propose a novel cardioprotective mechanism involving the E3 ubiquitin ligase HectD3, which links anti-hypertrophic and anti-inflammatory effects via dual regulation of SUMO2 and Stat1.

Untersuchungen zur Rolle des Epithelialen Zell-Adhäsionsmoleküls (EpCAM) bei der Biogenese von extrazellulären Vesikeln und deren pro-tumorigenem Phänotyp

Each cell in the human body constantly secretes microscopically small particles, the so-called extracellular vesicles. They act as messengers transferring components from the secreting to surrounding cells and can thus influence the latter. Cancer cells, in particular, release such vesicles to create a favourable organ microenvironment that favors tumor growth. In this project the mechanisms leading to vesicle release will be investigated in order to define novel therapeutic approaches that can block this process.

Biomarkers for molecular risk stratification in prostate cancer

The combination of MRI imaging and prostate biopsy often misses aggressive prostate carcinomas (PCa). Therefore, PCa diagnostics must be improved. Various tumor biological signaling pathways communicate directly with the action of male hormones, which are essential for PCa development. Factors from these signaling pathways are being investigated in blood and urine samples from 400 patients prior to MRI/ultrasound biopsy as potential PCa diagnostic markers.

PET/MRI for initial staging of squamous cell carcinoma of the head and neck (interSCCede PET/MRI)

Tumors of the head and neck are the most common types of tumors. Modern therapy concepts for advanced tumors rely on a combination of surgical tumor removal, radiation and chemotherapy. In order to choose the most sensible treatment regimen, the exact determination of the tumor extent is of particular importance. New hybrid imaging modalities, such as integrated positron emission tomography/magnetic resonance imaging (PET/MRI), enable the simultaneous visualization of tumor extent and tumor metabolism, which significantly increases the accuracy of imaging.